| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACIN1
|
apoptotic chromatin condensation inducer 1
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AVEN
|
apoptosis, caspase activation inhibitor
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BECN1
|
beclin 1, autophagy related
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMF
|
Bcl2 modifying factor
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CACYBP
|
calcyclin binding protein
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCDC50
|
coiled-coil domain containing 50
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CD247
|
CD247 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC37
|
cell division cycle 37
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK11B
|
cyclin-dependent kinase 11B
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CENPA
|
centromere protein A
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRYAB
|
crystallin, alpha B
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CYCS
|
cytochrome c, somatic
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DAP3
|
death associated protein 3
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DAXX
|
death-domain associated protein
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DNM1L
|
dynamin 1-like
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF3F
|
eukaryotic translation initiation factor 3, subunit F
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELK4
|
ELK4, ETS-domain protein (SRF accessory protein 1)
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
EYA3
|
EYA transcriptional coactivator and phosphatase 3
|
|
EZR
|
ezrin
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM129A
|
family with sequence similarity 129, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FHIT
|
fragile histidine triad
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GAP43
|
growth associated protein 43
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA4
|
GATA binding protein 4
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GOLGA3
|
golgin A3
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
H2AFX
|
H2A histone family, member X
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIST1H2BB
|
histone cluster 1, H2bb
|
|
HIST1H2BN
|
histone cluster 1, H2bn
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HIST3H2BA
|
histone cluster 3, H2ba, pseudogene
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
ICK
|
intestinal cell (MAK-like) kinase
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4R
|
interleukin 4 receptor
|
|
IL7R
|
interleukin 7 receptor
|
|
IP6K2
|
inositol hexakisphosphate kinase 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNB1
|
potassium channel, voltage gated Shab related subfamily B, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
KRT8
|
keratin 8, type II
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LAT
|
linker for activation of T cells
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LMTK1
|
lemur tail kinase 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
NBN
|
nibrin
|
|
NFE2L1
|
nuclear factor, erythroid 2-like 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NME3
|
NME/NM23 nucleoside diphosphate kinase 3
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PDCD5
|
programmed cell death 5
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PI4KB
|
phosphatidylinositol 4-kinase, catalytic, beta
|
|
PIDD1
|
p53-induced death domain protein 1
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PITPNB
|
phosphatidylinositol transfer protein, beta
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PLSCR3
|
phospholipid scramblase 3
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PSEN2
|
presenilin 2
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTRH2
|
peptidyl-tRNA hydrolase 2
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RPS3
|
ribosomal protein S3
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFN
|
stratifin
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SIRT1
|
sirtuin 1
|
|
SIVA1
|
SIVA1, apoptosis-inducing factor
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD5
|
SMAD family member 5
|
|
SMAD9
|
SMAD family member 9
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STK11
|
serine/threonine kinase 11
|
|
STK17B
|
serine/threonine kinase 17b
|
|
STK3
|
serine/threonine kinase 3
|
|
STK38
|
serine/threonine kinase 38
|
|
STK4
|
serine/threonine kinase 4
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SUDS3
|
suppressor of defective silencing 3 homolog (S. cerevisiae)
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAOK2
|
TAO kinase 2
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFRC
|
transferrin receptor
|
|
THEM4
|
thioesterase superfamily member 4
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TLR3
|
toll-like receptor 3
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TSC2
|
tuberous sclerosis 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
URI1
|
URI1, prefoldin-like chaperone
|
|
USF1
|
upstream transcription factor 1
|
|
USP28
|
ubiquitin specific peptidase 28
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VIM
|
vimentin
|
|
VRK1
|
vaccinia related kinase 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YAP1
|
Yes-associated protein 1
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZC3HC1
|
zinc finger, C3HC-type containing 1
|
|
ZNF420
|
zinc finger protein 420
|
|
ZNHIT1
|
zinc finger, HIT-type containing 1
|
|
ZYX
|
zyxin
|
